DOCSLIB.ORG

The Effect of Calcineurin Inhibition on the Expression and Activation of Renal Electrolyte Transporters

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

THE EFFECT OF CALCINEURIN INHIBITION ON THE EXPRESSION AND ACTIVATION OF RENAL ELECTROLYTE TRANSPORTERS King Yan Felice Leung A thesis submitted for the degree of Doctor of Philosophy September 2017 Neuroscience, Physiology & Pharmacology, Division of Biosciences University College London 1 Declaration I, King Yan Felice Leung confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. King Yan Felice Leung 2 Abstract Tacrolimus (FK506) is a calcineurin inhibitor (CNI), and the main immunosuppressant used in organ transplantation. It causes complications such as hypertension, hyperkalaemia, hypercalciuria and acidosis. Together with insulin resistance, dyslipidaemia and obesity, they comprise the metabolic syndrome. CNIs induce hypertension through the activation of the WNK-NCC cascade, causing an increase in sodium chloride reabsorption, and phosphorylation is an important post-translational modification that alters the activity of the members in the WNK-NCC cascade. Using quantitative phosphoproteomics and several bioinformatic techniques, a phosphoproteome profile of the renal cortices from FK506-treated mice was generated and phosphoproteins involved in renal tubular transport were identified. In this data, AKT was phosphorylated by FK506 and was suggested to act as the intermediary protein in the calcineurin-WNK cascade. In addition, ERK1/2 was also dysregulated by FK506 and was suggested to regulate NCC through the WNK4-ERK1/2 pathway. The phosphoproteome profile also revealed several FK506-dysregulated phosphoproteins that are involved in sodium, acid-base, glucose and potassium handling. CNIs have been suggested to cause hypercalciuria through a decrease in TRPV5 and calbindin-D28K expression, however, the effect of FK506 on other regulatory and transport proteins involved in calcium handling is unclear. In contrast to previous studies, FK506 did not dysregulate TRPV5 expression, but instead increased the expression of the basolateral calcium transporters, NCX1 and PMCA. Based on these findings, a novel mechanism explaining CNI-induced hypercalciuria, driven by the activation of NCC, is proposed and the relationship between sodium and calcium handling in the DCT is discussed. The effects of calcineurin inhibition on renal electrolyte transporters and their potential regulators induce salt-sensitive hypertension and hypercalciuria. The findings presented in this thesis contribute to the understanding of the underlying mechanism that governs sodium and calcium handling in the DCT and full elucidation of this molecular machinery is of interest and clinical importance. 3 Acknowledgements First of all, I would like to thank my supervisors, Dr. Stephen Benedict Walsh and Dr. Joanne Marks, for their unconditional support and patient guidance during my Ph.D. experience at the Centre for Nephrology in UCL. Their unlimited supply of encouragements allowed me to explore my ideas, which enabled me to achieve goals beyond my beliefs. I cannot stress the appreciation I have for both of them in providing the opportunities for me to work on several different projects and the chance to collaborate with different research groups, broadening my knowledge and sparking my interests in various fields of biology, and more importantly, for believing that I can get the job done. The opportunity to work with Professor Jasminka Godovac-Zimmermann and her research team gave me invaluable insights into the proteomics world. The quote, “You learn something new every day.” applied very literally and without the patient teachings of Dr. Benedetta Lombardi, this project would not have been as successful as it is now and on that note, I cannot emphasise on how appreciative I am of their help. I would also like to thank Dr. Anselm Zdebik for his detailed advice and ideas on the oocyte project. He inspired me to think innovatively and taught me many novel experimental techniques so that I could achieve the goals I originally set out. Special thanks to St. Peter’s Trust and UCL for my IMPACT studentship award, which funded and enabled me to complete these research projects. Furthermore, I would also like to thank my family for their care and willingness to answer every single one of my “emergency” phone calls, despite the time difference between London and Hong Kong. I would also like to thank Dr. Adam Dyer, Anne Kesselheim and Dr. Gregory Jacquillet for their support and ability to provide last-minute accommodations whenever I needed them. Finally, thanks must also go to the colleagues and staff from the Centre for Nephrology, for being the friendliest and most approachable group I have ever worked with; never have they hesitated or failed to answer any of my questions. 4 Abbreviations ACE Angiotensin-converting enzyme ADCY Adenylyl cyclase AKT Protein kinase B AMPK Adenosine monophosphate-activated protein kinase ANG Angiotensin AP3D1 AP-3 complex subunit delta-1 AQP2 Aquaporin-2 ASPA Animals (Scientific Procedures) Act ATP Adenosine triphosphate ATR Angiotensin II receptor AVPR2 Arginine vasopressin receptor 2 AWERB Animal Welfare and the ethical review body Broad-Complex, Tramtrack and Bric a brac-Cullin3- BCR RING-box protein 1 BK “big” K+ channel BSA Bovine serum albumin B-WNK3 Brain-WNK3 CACNA1E Calcium voltage-gated channel subunit α1E CaMK-II Calcium/calmodulin-dependent protein kinase II CaN Calcineurin CANX Calnexin CASK Calcium/calmodulin-dependent serine protein kinase CaSR Calcium-sensing receptor CD Collecting duct CD8 Cluster of differentiation 8 CDK Cyclin-dependent kinases CDPK Calcium-dependent protein kinase CK-II casein kinase II CLCN5 Hydrogen/chloride exchange transporter 5 CLCNKB Chloride voltage-gated channel Kb CNI Calcineurin inhibitor CNT Connecting tubule CUL3 Cullin-3 5 CYPIIB2 Aldosterone synthase CyA Cyclosporine A DCT Distal convoluted tubule DGKQ Diacylglycerol kinase theta DNA Deoxyribonucleic acid DTT Dithiothreitol Epilepsy, ataxia, sensorineural deafness and salt- EAST syndrome wasting renal tubulopathy EGF Epidermal growth factor EMA Epithelial membrane antigen ENaC Epithelial sodium channel eNOS Endothelial nitric oxide synthase ER Endoplasmic reticulum ERK1/2 Extracellular signal-regulated kinase 1 and 2 FGF23 Fibroblast growth factor 23 FHHt Familial hyperkalaemic hypertension FK506 Tacrolimus FKBP FK506 binding protein GSK3 Glycogen synthase kinase 3 HA Human influenza hemagglutinin HCD Higher energy collision dissociation HDL-C High-density lipoprotein cholesterol HEK 293H Human embryonic kidney 293 cells HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid HSD High sodium chloride diet HSP90AB1 Heat shock protein HSP 90-β IDH Isolated dominant hypomagnesaemia IGF1 insulin-like growth factor 1 IL Interleukin IMAC Immobilised metal affinity chromatography IP Intraperitoneal IP3R Inositol 1,4,5-trisphosphate receptors IRAK2 Interleukin-1 receptor-associated kinase 2 KCC Potassium chloride cotransporter 6 KCNJ Inward-rectifying potassium channel KLHL3 Kelch-like protein 3 Klotho β-glucuronidase klotho KS-WNK1 Kidney specific-WNK1 Kv1.1 Shaker-related voltage-gated potassium channel LAT4 L-type amino acid transporter 4 LB Lysogeny Broth LCM Laser capture microdissection LC-MS/MS Liquid chromatography-mass spectrometry LKB1 Liver kinase B1 MAPK Mitogen-activated protein kinase MAPK8IP4 Mitogen-activated protein kinase 8-interacting protein 4 MDCK Madin-darby canine kidney MO25 Mouse embryo scaffolding protein mDCT Mouse distal convoluted tubule MR Mineralocorticoid receptor MS Mass spectrometry mTOR Mechanistic/mammalian Target Of Rapamycin Na+/K+-ATPase Sodium-potassium adenosine triphosphatase NaPi Sodium phosphate cotransporter NBCe1 sodium bicarbonate cotransporter 1 NCC Sodium chloride cotransporter NCX1 Sodium/calcium exchanger 1 Nedd4 E3 ubiquitin-protein ligase NFATc Cytoplasmic nuclear factor of activated T cells NHE Sodium/hydrogen exchanger NHERF Sodium/hydrogen exchanger regulatory factor NKCC Sodium chloride potassium cotransporter NKCC2 Sodium chloride potassium cotransporter 2 NLK Nemo-Like Kinase NO Nitric oxide OSR1 Oxidative stress responsive kinase 1 PBS Phosphate-buffered saline PCR Polymerase chain reaction 7 PCT Proximal convoluted tubule PI3K Phosphatidylinositol 3-kinase PKA/C Protein kinase A/C PMCA Plasma membrane Ca2+ ATPase PNST Post-nuclear supernatant PPIase Peptidylprolyl cis-trans isomerase PsHP Pseudohypoparathyroidism PTH Parathyroid hormone PTH1R Parathyroid hormone 1 receptor PTK Protein tyrosine kinase PVDF Polyvinylidene difluoride RAAS Renin-angiotensin-aldosterone system RFx[V/I] Arg-Phe-Xaa-Val/Ile RLK Receptor-like kinase RLU/s Relative light units per seconds ROMK Renal outer medullary K+ channel SLC Solute carrier family SLC41A1 Solute carrier family 41 member 1 RTK Tyrosine kinase receptor Quantitative reverse transcription polymerase chain RT-qPCR reaction R-WNK3 Renal-WNK3 RyR Ryanodine receptor SDS Sodium dodecyl sulphate Sodium dodecyl sulphate-polyacrylamide SDS-PAGE electrophoresis SERCA Sarco endoplasmic reticulum calcium ATPase 2b SGK1 Serum and glucocorticoid-regulated kinase 1 SGLT2 sodium glucose cotransporter 2 SGPP1 Sphingosine-1-phosphatase 1 SNP Single nucleotide polymorphism SPAK STE20-like proline-alanine rich kinase SPNA2 Spectrin α-chain STRAD STE20 related adapter 8 TAE Tris-acetate-EDTA TALH Thick ascending limb of the loop of Henle TBS Tris-buffered saline TEAB Triethylammonium bicarbonate TM Transmembrane TMT Tandem mass tags TNF-α
Recommended publications
  • Gene Symbol Gene Description ACVR1B Activin a Receptor, Type IB

    Gene Symbol Gene Description ACVR1B Activin a Receptor, Type IB

    Table S1. Kinase clones included in human kinase cDNA library for yeast two-hybrid screening Gene Symbol Gene Description ACVR1B activin A receptor, type IB ADCK2 aarF domain containing kinase 2 ADCK4 aarF domain containing kinase 4 AGK multiple substrate lipid kinase;MULK AK1 adenylate kinase 1 AK3 adenylate kinase 3 like 1 AK3L1 adenylate kinase 3 ALDH18A1 aldehyde dehydrogenase 18 family, member A1;ALDH18A1 ALK anaplastic lymphoma kinase (Ki-1) ALPK1 alpha-kinase 1 ALPK2 alpha-kinase 2 AMHR2 anti-Mullerian hormone receptor, type II ARAF v-raf murine sarcoma 3611 viral oncogene homolog 1 ARSG arylsulfatase G;ARSG AURKB aurora kinase B AURKC aurora kinase C BCKDK branched chain alpha-ketoacid dehydrogenase kinase BMPR1A bone morphogenetic protein receptor, type IA BMPR2 bone morphogenetic protein receptor, type II (serine/threonine kinase) BRAF v-raf murine sarcoma viral oncogene homolog B1 BRD3 bromodomain containing 3 BRD4 bromodomain containing 4 BTK Bruton agammaglobulinemia tyrosine kinase BUB1 BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast) BUB1B BUB1 budding uninhibited by benzimidazoles 1 homolog beta (yeast) C9orf98 chromosome 9 open reading frame 98;C9orf98 CABC1 chaperone, ABC1 activity of bc1 complex like (S. pombe) CALM1 calmodulin 1 (phosphorylase kinase, delta) CALM2 calmodulin 2 (phosphorylase kinase, delta) CALM3 calmodulin 3 (phosphorylase kinase, delta) CAMK1 calcium/calmodulin-dependent protein kinase I CAMK2A calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha CAMK2B calcium/calmodulin-dependent
  • Download (Pdf)

    Download (Pdf)

    Invivoscribe's wholly-owned Laboratories for Personalized Molecular LabPMM LLC Medicine® (LabPMM) is a network of international reference laboratories that provide the medical and pharmaceutical communities with worldwide Located in San Diego, California, USA, it holds access to harmonized and standardized clinical testing services. We view the following accreditations and certifications: internationally reproducible and concordant testing as a requirement for ISO 15189, CAP, and CLIA, and is licensed to provide diagnostic consistent stratification of patients for enrollment in clinical trials, and the laboratory services in the states of California, Florida, foundation for establishing optimized treatment schedules linked to patient’s Maryland, New York, Pennsylvania, and Rhode Island. individual profile. LabPMM provides reliable patient stratification at diagnosis LabPMM GmbH and monitoring, throughout the entire course of treatment in support of Personalized Molecular Medicine® and Personalized Based in Martinsried (Munich), Germany. It is an ISO 15189 Molecular Diagnostics®. accredited international reference laboratory. CLIA/CAP accreditation is planned. Invivoscribe currently operates four clinical laboratories to serve partners in the USA (San Diego, CA), Europe (Munich, Germany), and Asia (Tokyo, Japan and Shanghai, China). These laboratories use the same critical LabPMM 合同会社 reagents and software which are developed consistently with ISO Located in Kawasaki (Tokyo), Japan and a licensed clinical lab. 13485 design control. Our cGMP reagents, rigorous standards for assay development & validation, and testing performed consistently under ISO 15189 requirements help ensure LabPMM generates standardized and concordant test results worldwide. Invivoscribe Diagnostic Technologies (Shanghai) Co., Ltd. LabPMM is an international network of PersonalMed Laboratories® focused on molecular oncology biomarker studies. Located in Shangai, China.
  • The Mineralocorticoid Receptor Leads to Increased Expression of EGFR

    The Mineralocorticoid Receptor Leads to Increased Expression of EGFR

    www.nature.com/scientificreports OPEN The mineralocorticoid receptor leads to increased expression of EGFR and T‑type calcium channels that support HL‑1 cell hypertrophy Katharina Stroedecke1,2, Sandra Meinel1,2, Fritz Markwardt1, Udo Kloeckner1, Nicole Straetz1, Katja Quarch1, Barbara Schreier1, Michael Kopf1, Michael Gekle1 & Claudia Grossmann1* The EGF receptor (EGFR) has been extensively studied in tumor biology and recently a role in cardiovascular pathophysiology was suggested. The mineralocorticoid receptor (MR) is an important efector of the renin–angiotensin–aldosterone‑system and elicits pathophysiological efects in the cardiovascular system; however, the underlying molecular mechanisms are unclear. Our aim was to investigate the importance of EGFR for MR‑mediated cardiovascular pathophysiology because MR is known to induce EGFR expression. We identifed a SNP within the EGFR promoter that modulates MR‑induced EGFR expression. In RNA‑sequencing and qPCR experiments in heart tissue of EGFR KO and WT mice, changes in EGFR abundance led to diferential expression of cardiac ion channels, especially of the T‑type calcium channel CACNA1H. Accordingly, CACNA1H expression was increased in WT mice after in vivo MR activation by aldosterone but not in respective EGFR KO mice. Aldosterone‑ and EGF‑responsiveness of CACNA1H expression was confrmed in HL‑1 cells by Western blot and by measuring peak current density of T‑type calcium channels. Aldosterone‑induced CACNA1H protein expression could be abrogated by the EGFR inhibitor AG1478. Furthermore, inhibition of T‑type calcium channels with mibefradil or ML218 reduced diameter, volume and BNP levels in HL‑1 cells. In conclusion the MR regulates EGFR and CACNA1H expression, which has an efect on HL‑1 cell diameter, and the extent of this regulation seems to depend on the SNP‑216 (G/T) genotype.
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model

    Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model

    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
  • Clustering of the Structures of Protein Kinase Activation Loops

    Clustering of the Structures of Protein Kinase Activation Loops

    bioRxiv preprint doi: https://doi.org/10.1101/395723; this version posted August 19, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Clustering of the structures of protein kinase activation loops: A new nomenclature for active and inactive kinase structures Vivek Modi Roland L. Dunbrack, Jr.* Institute for Cancer Research Fox Chase Cancer Center Philadelphia PA 19111 *[email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/395723; this version posted August 19, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Abstract TarGeting protein kinases is an important strateGy for intervention in cancer. Inhibitors are directed at the conserved active conformation or a variety of inactive conformations. While attempts have been made to classify these conformations, a structurally rigorous cataloGue of states has not been achieved. The kinase activation loop is crucial for catalysis and beGins with the conserved DFGmotif (Asp-Phe-Gly). This motif is observed in two major classes of conformations, DFGin - an ensemble of active and inactive conformations where the Phe residue is in contact with the C-helix of the N-terminal lobe, and DFGout - an inactive form where Phe occupies the ATP site exposinG the C-helix pocket.
  • Plasma Membrane Ca2+–Atpase in Rat and Human Odontoblasts Mediates Dentin Mineralization

    Plasma Membrane Ca2+–Atpase in Rat and Human Odontoblasts Mediates Dentin Mineralization

    biomolecules Article Plasma Membrane Ca2+–ATPase in Rat and Human Odontoblasts Mediates Dentin Mineralization Maki Kimura 1,†, Hiroyuki Mochizuki 1,†, Ryouichi Satou 2, Miyu Iwasaki 2, Eitoyo Kokubu 3, Kyosuke Kono 1, Sachie Nomura 1, Takeshi Sakurai 1, Hidetaka Kuroda 1,4,† and Yoshiyuki Shibukawa 1,*,† 1 Department of Physiology, Tokyo Dental College, 2-9-18, Kanda-Misaki-cho, Chiyoda-ku, Tokyo 101-0061, Japan; [email protected] (M.K.); [email protected] (H.M.); [email protected] (K.K.); [email protected] (S.N.); [email protected] (T.S.); [email protected] (H.K.) 2 Department of Epidemiology and Public Health, Tokyo Dental College, Chiyodaku, Tokyo 101-0061, Japan; [email protected] (R.S.); [email protected] (M.I.) 3 Department of Microbiology, Tokyo Dental College, Chiyodaku, Tokyo 101-0061, Japan; [email protected] 4 Department of Dental Anesthesiology, Kanagawa Dental University, 1-23, Ogawacho, Kanagawa, Yokosuka-shi 238-8570, Japan * Correspondence: [email protected] † These authors contributed equally to this study. Abstract: Intracellular Ca2+ signaling engendered by Ca2+ influx and mobilization in odontoblasts is critical for dentinogenesis induced by multiple stimuli at the dentin surface. Increased Ca2+ is exported by the Na+–Ca2+ exchanger (NCX) and plasma membrane Ca2+–ATPase (PMCA) to Citation: Kimura, M.; Mochizuki, H.; maintain Ca2+ homeostasis. We previously demonstrated a functional coupling between Ca2+ Satou, R.; Iwasaki, M.; Kokubu, E.; extrusion by NCX and its influx through transient receptor potential channels in odontoblasts. Kono, K.; Nomura, S.; Sakurai, T.; Although the presence of PMCA in odontoblasts has been previously described, steady-state levels of Kuroda, H.; Shibukawa, Y.
  • Ubiquitin Ligase Trim32 and Chloride-Sensitive WNK1 As Regulators of Potassium Channels in the Brain Eugene Miler Cilento University of Vermont

    Ubiquitin Ligase Trim32 and Chloride-Sensitive WNK1 As Regulators of Potassium Channels in the Brain Eugene Miler Cilento University of Vermont

    University of Vermont ScholarWorks @ UVM Graduate College Dissertations and Theses Dissertations and Theses 2015 Ubiquitin Ligase Trim32 and Chloride-sensitive WNK1 as Regulators of Potassium Channels in the Brain Eugene Miler Cilento University of Vermont Follow this and additional works at: http://scholarworks.uvm.edu/graddis Part of the Neurosciences Commons, and the Pharmacology Commons Recommended Citation Cilento, Eugene Miler, "Ubiquitin Ligase Trim32 and Chloride-sensitive WNK1 as Regulators of Potassium Channels in the Brain" (2015). Graduate College Dissertations and Theses. Paper 431. This Dissertation is brought to you for free and open access by the Dissertations and Theses at ScholarWorks @ UVM. It has been accepted for inclusion in Graduate College Dissertations and Theses by an authorized administrator of ScholarWorks @ UVM. For more information, please contact [email protected]. UBIQUITIN LIGASE TRIM32 AND CHLORIDE-SENSITIVE WNK1 AS REGULATORS OF POTASSIUM CHANNELS IN THE BRAIN A Dissertation Presented by Eugene Miler Cilento to The Faculty of the Graduate College of The University of Vermont In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Specializing in Neuroscience October, 2015 Defense Date: August 04, 2014 Dissertation Examination Committee: Anthony Morielli, Ph.D., Advisor John Green, Ph.D., Chairperson Bryan Ballif, Ph.D. Wolfgang Dostmann Ph.D. George Wellman, Ph.D. Cynthia J. Forehand, Ph.D., Dean of the Graduate College ABSTRACT The voltage-gated potassium channel Kv1.2 impacts membrane potential and therefore excitability of neurons. Expression of Kv1.2 at the plasma membrane (PM) is critical for channel function, and altering Kv1.2 at the PM is one way to affect membrane excitability.
  • To Study Mutant P53 Gain of Function, Various Tumor-Derived P53 Mutants

    To Study Mutant P53 Gain of Function, Various Tumor-Derived P53 Mutants

    Differential effects of mutant TAp63γ on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression. A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science By Shama K Khokhar M.Sc., Bilaspur University, 2004 B.Sc., Bhopal University, 2002 2007 1 COPYRIGHT SHAMA K KHOKHAR 2007 2 WRIGHT STATE UNIVERSITY SCHOOL OF GRADUATE STUDIES Date of Defense: 12-03-07 I HEREBY RECOMMEND THAT THE THESIS PREPARED UNDER MY SUPERVISION BY SHAMA KHAN KHOKHAR ENTITLED Differential effects of mutant TAp63γ on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression BE ACCEPTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF Master of Science Madhavi P. Kadakia, Ph.D. Thesis Director Daniel Organisciak , Ph.D. Department Chair Committee on Final Examination Madhavi P. Kadakia, Ph.D. Steven J. Berberich, Ph.D. Michael Leffak, Ph.D. Joseph F. Thomas, Jr., Ph.D. Dean, School of Graduate Studies 3 Abstract Khokhar, Shama K. M.S., Department of Biochemistry and Molecular Biology, Wright State University, 2007 Differential effect of TAp63γ mutants on transactivation of p53 and/or p63 responsive genes and their effects on global gene expression. p63, a member of the p53 gene family, known to play a role in development, has more recently also been implicated in cancer progression. Mice lacking p63 exhibit severe developmental defects such as limb truncations, abnormal skin, and absence of hair follicles, teeth, and mammary glands. Germline missense mutations of p63 have been shown to be responsible for several human developmental syndromes including SHFM, EEC and ADULT syndromes and are associated with anomalies in the development of organs of epithelial origin.
  • Profiling Data

    Profiling Data

    Compound Name DiscoveRx Gene Symbol Entrez Gene Percent Compound Symbol Control Concentration (nM) BSJ-03-123 AAK1 AAK1 94 1000 BSJ-03-123 ABL1(E255K)-phosphorylated ABL1 79 1000 BSJ-03-123 ABL1(F317I)-nonphosphorylated ABL1 89 1000 BSJ-03-123 ABL1(F317I)-phosphorylated ABL1 98 1000 BSJ-03-123 ABL1(F317L)-nonphosphorylated ABL1 86 1000 BSJ-03-123 ABL1(F317L)-phosphorylated ABL1 89 1000 BSJ-03-123 ABL1(H396P)-nonphosphorylated ABL1 76 1000 BSJ-03-123 ABL1(H396P)-phosphorylated ABL1 90 1000 BSJ-03-123 ABL1(M351T)-phosphorylated ABL1 100 1000 BSJ-03-123 ABL1(Q252H)-nonphosphorylated ABL1 56 1000 BSJ-03-123 ABL1(Q252H)-phosphorylated ABL1 97 1000 BSJ-03-123 ABL1(T315I)-nonphosphorylated ABL1 100 1000 BSJ-03-123 ABL1(T315I)-phosphorylated ABL1 85 1000 BSJ-03-123 ABL1(Y253F)-phosphorylated ABL1 100 1000 BSJ-03-123 ABL1-nonphosphorylated ABL1 60 1000 BSJ-03-123 ABL1-phosphorylated ABL1 79 1000 BSJ-03-123 ABL2 ABL2 89 1000 BSJ-03-123 ACVR1 ACVR1 100 1000 BSJ-03-123 ACVR1B ACVR1B 95 1000 BSJ-03-123 ACVR2A ACVR2A 100 1000 BSJ-03-123 ACVR2B ACVR2B 96 1000 BSJ-03-123 ACVRL1 ACVRL1 84 1000 BSJ-03-123 ADCK3 CABC1 90 1000 BSJ-03-123 ADCK4 ADCK4 91 1000 BSJ-03-123 AKT1 AKT1 100 1000 BSJ-03-123 AKT2 AKT2 98 1000 BSJ-03-123 AKT3 AKT3 100 1000 BSJ-03-123 ALK ALK 100 1000 BSJ-03-123 ALK(C1156Y) ALK 78 1000 BSJ-03-123 ALK(L1196M) ALK 100 1000 BSJ-03-123 AMPK-alpha1 PRKAA1 93 1000 BSJ-03-123 AMPK-alpha2 PRKAA2 100 1000 BSJ-03-123 ANKK1 ANKK1 89 1000 BSJ-03-123 ARK5 NUAK1 98 1000 BSJ-03-123 ASK1 MAP3K5 100 1000 BSJ-03-123 ASK2 MAP3K6 92 1000 BSJ-03-123 AURKA
  • The Chondrocyte Channelome: a Novel Ion Channel Candidate in the Pathogenesis of Pectus Deformities

    The Chondrocyte Channelome: a Novel Ion Channel Candidate in the Pathogenesis of Pectus Deformities

    Old Dominion University ODU Digital Commons Biological Sciences Theses & Dissertations Biological Sciences Summer 2017 The Chondrocyte Channelome: A Novel Ion Channel Candidate in the Pathogenesis of Pectus Deformities Anthony J. Asmar Old Dominion University, [email protected] Follow this and additional works at: https://digitalcommons.odu.edu/biology_etds Part of the Biology Commons, Molecular Biology Commons, and the Physiology Commons Recommended Citation Asmar, Anthony J.. "The Chondrocyte Channelome: A Novel Ion Channel Candidate in the Pathogenesis of Pectus Deformities" (2017). Doctor of Philosophy (PhD), Dissertation, Biological Sciences, Old Dominion University, DOI: 10.25777/pyha-7838 https://digitalcommons.odu.edu/biology_etds/19 This Dissertation is brought to you for free and open access by the Biological Sciences at ODU Digital Commons. It has been accepted for inclusion in Biological Sciences Theses & Dissertations by an authorized administrator of ODU Digital Commons. For more information, please contact [email protected]. THE CHONDROCYTE CHANNELOME: A NOVEL ION CHANNEL CANDIDATE IN THE PATHOGENESIS OF PECTUS DEFORMITIES by Anthony J. Asmar B.S. Biology May 2010, Virginia Polytechnic Institute M.S. Biology May 2013, Old Dominion University A Dissertation Submitted to the Faculty of Old Dominion University in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY BIOMEDICAL SCIENCES OLD DOMINION UNIVERSITY August 2017 Approved by: Christopher Osgood (Co-Director) Michael Stacey (Co-Director) Lesley Greene (Member) Andrei Pakhomov (Member) Jing He (Member) ABSTRACT THE CHONDROCYTE CHANNELOME: A NOVEL ION CHANNEL CANDIDATE IN THE PATHOGENESIS OF PECTUS DEFORMITIES Anthony J. Asmar Old Dominion University, 2017 Co-Directors: Dr. Christopher Osgood Dr. Michael Stacey Costal cartilage is a type of rod-like hyaline cartilage connecting the ribs to the sternum.
  • Src-Family Kinases Impact Prognosis and Targeted Therapy in Flt3-ITD+ Acute Myeloid Leukemia

    Src-Family Kinases Impact Prognosis and Targeted Therapy in Flt3-ITD+ Acute Myeloid Leukemia

    Src-Family Kinases Impact Prognosis and Targeted Therapy in Flt3-ITD+ Acute Myeloid Leukemia Title Page by Ravi K. Patel Bachelor of Science, University of Minnesota, 2013 Submitted to the Graduate Faculty of School of Medicine in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Pittsburgh 2019 Commi ttee Membership Pa UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE Commi ttee Membership Page This dissertation was presented by Ravi K. Patel It was defended on May 31, 2019 and approved by Qiming (Jane) Wang, Associate Professor Pharmacology and Chemical Biology Vaughn S. Cooper, Professor of Microbiology and Molecular Genetics Adrian Lee, Professor of Pharmacology and Chemical Biology Laura Stabile, Research Associate Professor of Pharmacology and Chemical Biology Thomas E. Smithgall, Dissertation Director, Professor and Chair of Microbiology and Molecular Genetics ii Copyright © by Ravi K. Patel 2019 iii Abstract Src-Family Kinases Play an Important Role in Flt3-ITD Acute Myeloid Leukemia Prognosis and Drug Efficacy Ravi K. Patel, PhD University of Pittsburgh, 2019 Abstract Acute myelogenous leukemia (AML) is a disease characterized by undifferentiated bone-marrow progenitor cells dominating the bone marrow. Currently the five-year survival rate for AML patients is 27.4 percent. Meanwhile the standard of care for most AML patients has not changed for nearly 50 years. We now know that AML is a genetically heterogeneous disease and therefore it is unlikely that all AML patients will respond to therapy the same way. Upregulation of protein-tyrosine kinase signaling pathways is one common feature of some AML tumors, offering opportunities for targeted therapy.
  • Optimisation and Validation of a High Throughput Screening Compatible

    Optimisation and Validation of a High Throughput Screening Compatible

    J Pharm Pharmaceut Sci (www.cspsCanada.org) 16(2) 217 - 230, 2013 Optimisation and Validation of a High Throughput Screening Compatible Assay to Identify Inhibitors of the Plasma Membrane Calcium ATPase Pump - a Novel Therapeutic Target for Contraception and Malaria Tamer M A Mohamed1,2, Simon A Zakeri1, Florence Baudoin1, Markus Wolf3, Delvac Oceandy1, Elizabeth J Cartwright1, Sheraz Gul3, Ludwig Neyses1 1 Institute of Cardiovascular Sciences, Manchester Academic Health Sciences Centre, University of Manchester, Manchester M13 9PT, UK. 2 Dept. of Biochemistry, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt. 3 European ScreeningPort GmbH, 22525 Hamburg, Germany. Received, March 13, 2013; Revised, April 25, 2013; Accepted, May 8th, 2013; Published, May 10th, 2013. ABSTRACT – Purpose. ATPases, which constitute a major category of ion transporters in the human body, have a variety of significant biological and pathological roles. However, the lack of high throughput assays for ATPases has significantly limited drug discovery in this area. We have recently found that the genetic deletion of the ATP dependent calcium pump PMCA4 (plasma membrane calcium/calmodulin dependent ATPase, isoform 4) results in infertility in male mice due to a selective defect in sperm motility. In addition, recent discoveries in humans have indicated that a single nucleotide polymorphism (SNP) in the PMCA4 gene determines the susceptibility towards malaria plasmodium infection. Therefore, there is an urgent need to develop specific PMCA4 inhibitors. In the current study, we aim to optimise and validate a high throughput screening compatible assay using recombinantly expressed PMCA4 and the HTRF® Transcreener® ADP (TR-FRET) assay to screen a drug library. Methods and Results.